mRNA expression profiles obtained from microdissected pancreatic cancer cells can predict patient survival

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most devastating malignancies in developed countries because of its very poor prognosis and high mortality rates. By the time PDAC is usually diagnosed only 20-25% of patients are candidates for surgery, and the rate of survival for t...

Descripción completa

Detalles Bibliográficos
Autores principales: García-García, Ana-Barbara, Gómez-Mateo, M. Carmen, Hilario, Rebeca, Rentero-Garrido, Pilar, Martínez-Domenech, Alvaro, Gonzalez-Albert, Veronica, Cervantes, Andres, Marín-Garcia, Pablo, Chaves, Felipe Javier, Ferrández-Izquierdo, Antonio, Sabater, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739601/
https://www.ncbi.nlm.nih.gov/pubmed/29285214
http://dx.doi.org/10.18632/oncotarget.20076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739601/
https://www.ncbi.nlm.nih.gov/pubmed/29285214
http://dx.doi.org/10.18632/oncotarget.20076

Ejemplares similares